https://oculusbiomed.com.au/melbourne-australia/batch-of-obm-1701-was-successfully/2023-01-18T02:42:41+00:00https://oculusbiomed.com.au/melbourne-australia/obm-1701-granted/2023-01-18T02:42:48+00:00https://oculusbiomed.com.au/melbourne-australia/obm-signs/2023-01-18T02:42:53+00:00https://oculusbiomed.com.au/melbourne-australia/obm-terminates-acquisition/2023-01-18T02:42:59+00:00https://oculusbiomed.com.au/melbourne-australia/key-chinese-patent-covering-obm/2023-01-18T02:43:08+00:00https://oculusbiomed.com.au/melbourne-australia/obm-enters-rd-agreement/2023-01-18T02:43:03+00:00https://oculusbiomed.com.au/melbourne-australia/obm-allowed/2023-01-18T02:43:14+00:00https://oculusbiomed.com.au/melbourne-australia/melbourne-australia-2-june-2021-key-eu-patent-covering-obm-1701-granted/2023-01-18T02:43:18+00:00https://oculusbiomed.com.au/melbourne-australia/melbourne-australia-11-june-2021-key-chinese-patent-covering-obm-1701-granted/2023-01-18T02:43:22+00:00https://oculusbiomed.com.au/melbourne-australia/melbourne-australia-05-october-2021-obm-enters-rd-agreement-with-centre-for-eye-research-australia-cera/2023-01-18T02:43:29+00:00https://oculusbiomed.com.au/melbourne-australia/melbourne-australia-22-february-2022-research-data-which-covers-obms-obm-1701-for-the-treatment-of-wet-amd-has-been-published-on-a-prominent-peer-reviewed-journal/2023-01-18T02:44:11+00:00https://oculusbiomed.com.au/adelaide-australia/ausmedtech-conference-adelaide-24th-25th-may-2023/2023-08-28T00:53:37+00:00https://oculusbiomed.com.au/melbourne-australia/professor-robyn-guymer-am-appointed-to-obm-scientific-board1st-july-2023/2023-08-28T00:54:32+00:00https://oculusbiomed.com.au/tainan-taiwan/acro-biomedicals-krisan-biotech-site-visit-tainan-taiwan-25th-july-2023/2023-08-28T01:04:22+00:00https://oculusbiomed.com.au/taiwan/obm-presented-at-bioasia-taipei-taiwan-26th-30th-july-2023/2023-08-28T01:09:26+00:00https://oculusbiomed.com.au/singapore/tan-tock-seng-hospital-singapore-site-visit-by-ceo-2nd-august-2023/2023-08-28T01:11:04+00:00https://oculusbiomed.com.au/melbourne-australia/oculus-biomed-limited-partners-with-the-centre-for-eye-research-australia-cera-in-a-deal-to-develop-switchgene-eye-gene-therapies-11-oct-2023/2023-10-09T03:11:20+00:00https://oculusbiomed.com.au/melbourne-australia/ms-michelle-gallaher-appointed-non-executive-director-01-oct-2023/2023-10-09T04:10:48+00:00https://oculusbiomed.com.au/melbourne-australia/mr-roger-mcpherson-appointed-cfo-company-secretary-27-nov-2023/2023-11-27T00:26:16+00:00https://oculusbiomed.com.au/melbourne-australia/ausbiotech-conference-brisbane-1-3-nov-2023/2023-11-27T00:28:14+00:00https://oculusbiomed.com.au/uncategorized/obm-was-invited-by-our-legal-advisor-firm-steinepreis-paganin-to-attend-ipo-networks-exclusive-event-in-melbourne-30th-july-2025/2025-08-31T02:21:24+00:00https://oculusbiomed.com.au/uncategorized/obm-attends-bioasia-taiwan-conference-and-acro-biomedical-announces-to-outlicense-the-market-rights-in-10-asean-countries-of-its-biocompatible-artificial-cornea-abccolla-collagen-ophthalmic-matrix-t/2025-08-31T02:23:19+00:00https://oculusbiomed.com.au/uncategorized/professor-mark-daniell-joined-to-obm-scientific-board-14th-july-2025/2025-08-31T02:24:07+00:00https://oculusbiomed.com.au/uncategorized/our-partner-acro-biomedical-co-ltd-receives-approval-for-its-biocompatible-cornea-from-taiwan-fda-the-department-of-health-and-welfare-14th-march-2025/2025-08-31T02:24:47+00:00https://oculusbiomed.com.au/melbourne-australia/data-indicate-obms-obm1701-diffuses-into-the-retina-and-rpe-and-effectively-alleviates-choroidal-neovascularisation-in-wet-amd-animal-model-after-topically-applied-has-been-published-on-an-as/2025-09-11T22:08:21+00:00